Remedium Lifecare Ltd Quarterly Results
Q2 FY25-26 Results Summary
Revenue
The revenue stands at ₹111.06 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.04 per cent from ₹113.37 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit
Operating Profit stands at ₹7.37 crore, reflecting a quarter-on-quarter *(QoQ) increase of 294.12 per cent from ₹1.87 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
PBDT
PBDT stands at ₹10.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.66 per cent from ₹5.71 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹10.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.66 per cent from ₹5.71 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Net Profit
Net Profit stands at ₹8.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 85.38 per cent from ₹4.65 crore. This represents a 0.00 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Remedium Lifecare Ltd Earnings
- YOY
- QOQ
Remedium Lifecare Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Remedium Lifecare Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Remedium Lifecare Ltd Financial Reports
Remedium Lifecare Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Remedium Life | 4.00% | -3.70% | -7.14% | -23.53% | -25.71% | -83.12% |
| Medico Intercon. | 6.76% | 9.12% | 7.58% | -7.49% | -6.32% | -26.25% |
| Ishita Drugs | 0.19% | 8.11% | 8.11% | 9.45% | -0.67% | 8.09% |
| Deep Health AI | 1.24% | -1.21% | -12.83% | -22.38% | -13.76% | -71.85% |
| Venmax Drugs | 2.35% | -0.14% | -5.19% | -20.78% | -38.32% | -22.20% |
| Pentokey Organy | 1.30% | -8.07% | -1.44% | -7.36% | -5.55% | -30.11% |
| Shree Ganesh Bio | 2.13% | 2.13% | -5.88% | -14.29% | -26.15% | -36.00% |
Company Info
Company Information
Whole-time Director : Adarsh Deepak Munjal
Independent Non Exe. Director : Dipesh Vaidya
Independent Non Exe. Director : Shamim Adil Michal
Independent Non Exe. Director : Bikram Kumar Mund
Independent Non Exe. Director : VIJAY PAL SINGH GULYA
Company Sec. & Compli. Officer : Kapil Goplani